Investor Contact

Primary IR Contact
Thomas Soloway
SVP and Chief Financial Officer
Audentes Therapeutics, Inc.
E-mail: ir@audentestx.com


To request information, please fill out and submit the form below:
Personal InformationRequired fields denoted by an asterisk (*).
First Name*Last Name*
TitleOrganization
Investor Type
Address 1Address 2
CityState / Province
Zip Code / Zone
Country
PhoneFax
E-mail*
Questions / Comments